Drugs for kids: good or bad?
作者信息
Albert Paul R
出版信息
J Psychiatry Neurosci. 2012 Sep;37(5):293-5. doi: 10.1503/jpn.120140.
Abstract
摘要
相似文献
1
Drugs for kids: good or bad?
J Psychiatry Neurosci. 2012 Sep;37(5):293-5. doi: 10.1503/jpn.120140.
2
[Antipsychotic agents and stimulants: a judicious combination?].
Tijdschr Psychiatr. 2010;52(1):57-61.
3
Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.
J Clin Psychopharmacol. 2010 Feb;30(1):77-8. doi: 10.1097/JCP.0b013e3181c92eb2.
4
Mood drugs.
Dis Mon. 1977 Nov;24(2):1-65. doi: 10.1016/s0011-5029(77)80016-3.
5
Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.
Australas Psychiatry. 2008 Dec;16(6):458-9. doi: 10.1177/000486740801600602.
6
Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
J Clin Psychiatry. 2011 May;72(5):655-70. doi: 10.4088/JCP.11r07064.
7
Management of psychopharmacologic agents in children and adolescents.
Psychiatr Q. 1992 Winter;63(4):391-411. doi: 10.1007/BF01066765.
8
Medications used in the treatment of disruptive behavior in children with FASD--a guide.
J Popul Ther Clin Pharmacol. 2015;22(1):e59-67. Epub 2015 Feb 12.
9
Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder.
J Atten Disord. 2009 Sep;13(2):197-8. doi: 10.1177/1087054709332407. Epub 2009 Apr 20.
10
From the Editor-in-Chief's Desk.
J Child Adolesc Psychopharmacol. 2015 Oct;25(8):601. doi: 10.1089/cap.2015.29029.hsk.
引用本文的文献
1
The impact of prescription drug co-payments for publicly insured families.
Eur J Health Econ. 2020 Mar;21(2):261-274. doi: 10.1007/s10198-019-01125-3. Epub 2019 Nov 8.
本文引用的文献
1
Distinct age-dependent effects of methylphenidate on developing and adult prefrontal neurons.
Biol Psychiatry. 2012 Nov 15;72(10):880-8. doi: 10.1016/j.biopsych.2012.04.018. Epub 2012 May 19.
2
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.
BMJ. 2012 Apr 5;344:e2233. doi: 10.1136/bmj.e2233.
3
Stimulant medication use in children: a 12-year perspective.
Am J Psychiatry. 2012 Feb;169(2):160-6. doi: 10.1176/appi.ajp.2011.11030387.
4
Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes.
J Abnorm Child Psychol. 2012 Aug;40(6):1013-26. doi: 10.1007/s10802-012-9610-2.
5
Methylphenidate and risk of serious cardiovascular events in adults.
Am J Psychiatry. 2012 Feb;169(2):178-85. doi: 10.1176/appi.ajp.2011.11010125.
6
ADHD pharmacotherapy: rates of stimulant use and cardiovascular risk.
Am J Psychiatry. 2012 Feb;169(2):112-4. doi: 10.1176/appi.ajp.2011.11111703.
7
Juvenile exposure to methylphenidate reduces cocaine reward and alters netrin-1 receptor expression in adulthood.
Behav Brain Res. 2012 Apr 1;229(1):202-7. doi: 10.1016/j.bbr.2012.01.008. Epub 2012 Jan 13.
8
Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35. doi: 10.1089/cap.2011.0015. Epub 2011 Dec 13.
9
ADHD drugs and serious cardiovascular events in children and young adults.
N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.
10
Temporal dynamics and genetic control of transcription in the human prefrontal cortex.
Nature. 2011 Oct 26;478(7370):519-23. doi: 10.1038/nature10524.
Zotero 插件